GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » NantHealth Inc (OTCPK:NHIQ) » Definitions » Profitability Rank

NantHealth (NantHealth) Profitability Rank : 2 (As of Sep. 2023)


View and export this data going back to 2016. Start your Free Trial

What is NantHealth Profitability Rank?

NantHealth has the Profitability Rank of 2. It has had trouble to make a profit.

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way. It is based on these factors:

1. Operating Margin %
2. Piotroski F-Score
3. Trend of the Operating Margin % (5-year average). The company with an uptrend profit margin has a higher rank.
4. Consistency of the profitability
5. Predictability Rank

NantHealth's Operating Margin % for the quarter that ended in Sep. 2023 was -40.16%. As of today, NantHealth's Piotroski F-Score is 4.


Competitive Comparison of NantHealth's Profitability Rank

For the Health Information Services subindustry, NantHealth's Profitability Rank, along with its competitors' market caps and Profitability Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NantHealth's Profitability Rank Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, NantHealth's Profitability Rank distribution charts can be found below:

* The bar in red indicates where NantHealth's Profitability Rank falls into.



NantHealth Profitability Rank Calculation

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

NantHealth has the Profitability Rank of 2. It has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength. But if a company is consistently profitable, its financial strength will be stronger.

Profitability Rank is based on these factors:

1. Operating Margin %

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

NantHealth's Operating Margin % for the quarter that ended in Sep. 2023 is calculated as:

Operating Margin %=Operating Income (Q: Sep. 2023 ) / Revenue (Q: Sep. 2023 )
=-5.007 / 12.468
=-40.16 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

2. Piotroski F-Score

The zones of discrimination were as such:

Good or high score = 8 or 9
Bad or low score = 0 or 1

NantHealth has an F-score of 4 indicating the company's financial situation is typical for a stable company.

3. Trend of the Operating Margin % (5-year average). The company with an uptrend profit margin has a higher rank.

4. Consistency of the profitability

5. Predictability Rank


NantHealth Profitability Rank Related Terms

Thank you for viewing the detailed overview of NantHealth's Profitability Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


NantHealth (NantHealth) Business Description

Traded in Other Exchanges
N/A
Address
3000 RDU Center Drive, Suite 200, Morrisville, NC, USA, 27500
NantHealth Inc is a healthcare company that employs precision medicine and technology to give physicians, payers, and patients more information. The company develops software and hardware to collect, indexes, analyze and interpret molecular, financial, clinical, and operational data points to improve decision-making. The company provides cancer care solutions, provide solutions, and payer solutions.
Executives
Rao Haris Naseem director, 10 percent owner, officer: Chief Executive Officer C/O NANTHEALTH, INC., 760 W. FIRE TOWER RD., SUITE 107, WINTERVILLE NC 28590
Summus Holdings Llc 10 percent owner 2871 LAKE VISTA DR, SUITE 210, LEWISVILLE TX 75067
Ronald Allen Louks officer: Chief Operating Officer C/O NANTHEALTH, INC., 9920 JEFFERSON BLVD., CULVER CITY CA 90232
Nant Capital, Llc 10 percent owner 9922 JEFFERSON BOULEVARD, CULVER CITY CA 90232
Patrick Soon-shiong director, 10 percent owner, officer: See Remarks 9922 JEFFERSON BOULEVARD, CULVER CITY CA 90232
Deanna L. Wise director C/O NANTHEALTH, INC., 9920 JEFFERSON BLVD, CULVER CITY CA 90232
Bob Petrou officer: Interim CFO C/O NANTHEALTH, INC., 9920 JEFFERSON BLVD., CULVER CITY CA 90232
Mp 13 Ventures, Llc 10 percent owner 9922 JEFFERSON BOULEVARD, CULVER CITY CA 90232
Cambridge Equities, Lp 10 percent owner 9922 JEFFERSON BOULEVARD, CULVER CITY CA 90232
Allscripts Healthcare Solutions, Inc. 10 percent owner 222 MERCHANDISE MART PLAZA, SUITE 2024, CHICAGO IL 60654
Nantworks, Llc 10 percent owner 9922 JEFFERSON BOULEVARD, CULVER CITY CA 90232
Investment Office Kuwait 10 percent owner 15 CARTER LANE, LONDON X0 EC4V 5EY
Miller Edward D Jr director JOHNS HOPKINS, 733 NORTH BROADWAY - SUITE 100, BALTIMORE MD 21205
Kuwait Investment Authority On Behalf Of The Govt Of Kuwait 10 percent owner C/O HOMEPLACE OF AMERICA INC, 3200 POTTERY DRIVE, MYRTLE BEACH SC 29579
James Mark Burnett director 640 N. SEPULVEDA BLVD., LOS ANGELES CA 90049

NantHealth (NantHealth) Headlines

From GuruFocus

NantHealth Announces 1-for-15 Reverse Stock Split

By Business Wire Business Wire 12-15-2022

NantHealth to Present at the Cowen 42nd Annual Health Care Conference

By Business Wire Business Wire 03-07-2022

NantHealth Launches Eviti Connect For Autoimmune Diseases

By Business Wire Business Wire 05-05-2021